Few countries can match India on scale and complexity of a nationwide rollout of any item under the sun. Be it the general elections or the covid-19 inoculation plan of over 300m citizens by the end of the summer. India faces a daunting task but appears to be up for it. Covaxin, the home-grown vaccine has kicked up some controversy. Data of stage 3 clinical trials have not been yet made available. How are other countries faring? And in other news the legendary Mahinder Watsa, a trained obstetrician-gynaecologist-turned-sexpert passed away recently. He was known for his witty and dry remarks on all things sex. And which is Japan's oldest company still alive and kicking?